nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—CYP2D6—Hydroxyurea—head and neck cancer	0.175	0.238	CbGbCtD
Trazodone—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.111	0.151	CbGbCtD
Trazodone—CYP3A7—Docetaxel—head and neck cancer	0.111	0.151	CbGbCtD
Trazodone—CYP3A5—Docetaxel—head and neck cancer	0.0832	0.113	CbGbCtD
Trazodone—ABCB1—Vinblastine—head and neck cancer	0.0657	0.0896	CbGbCtD
Trazodone—CYP2D6—Vinblastine—head and neck cancer	0.0619	0.0844	CbGbCtD
Trazodone—ABCB1—Docetaxel—head and neck cancer	0.0541	0.0738	CbGbCtD
Trazodone—CYP3A4—Vinblastine—head and neck cancer	0.0393	0.0537	CbGbCtD
Trazodone—CYP3A4—Docetaxel—head and neck cancer	0.0324	0.0442	CbGbCtD
Trazodone—Death—Docetaxel—head and neck cancer	0.0148	0.0592	CcSEcCtD
Trazodone—Nail discolouration—Docetaxel—head and neck cancer	0.0136	0.0545	CcSEcCtD
Trazodone—Speech impairment NOS—Fluorouracil—head and neck cancer	0.0109	0.0433	CcSEcCtD
Trazodone—Inappropriate antidiuretic hormone secretion—Vinblastine—head and neck cancer	0.00622	0.0248	CcSEcCtD
Trazodone—Eruption—Hydroxyurea—head and neck cancer	0.00536	0.0214	CcSEcCtD
Trazodone—Slurred speech—Fluorouracil—head and neck cancer	0.0053	0.0212	CcSEcCtD
Trazodone—Numbness—Vinblastine—head and neck cancer	0.00436	0.0174	CcSEcCtD
Trazodone—Balance disorder—Fluorouracil—head and neck cancer	0.00434	0.0173	CcSEcCtD
Trazodone—Sensory loss—Vinblastine—head and neck cancer	0.00417	0.0166	CcSEcCtD
Trazodone—Photophobia—Vinblastine—head and neck cancer	0.00339	0.0135	CcSEcCtD
Trazodone—Menstruation irregular—Docetaxel—head and neck cancer	0.00309	0.0123	CcSEcCtD
Trazodone—Deafness—Vinblastine—head and neck cancer	0.00293	0.0117	CcSEcCtD
Trazodone—Numbness—Fluorouracil—head and neck cancer	0.00286	0.0114	CcSEcCtD
Trazodone—Eruption—Docetaxel—head and neck cancer	0.00278	0.0111	CcSEcCtD
Trazodone—Speech disorder—Fluorouracil—head and neck cancer	0.00276	0.011	CcSEcCtD
Trazodone—Sensory loss—Fluorouracil—head and neck cancer	0.00274	0.0109	CcSEcCtD
Trazodone—Cerebrovascular accident—Vinblastine—head and neck cancer	0.00268	0.0107	CcSEcCtD
Trazodone—Disorientation—Hydroxyurea—head and neck cancer	0.00267	0.0107	CcSEcCtD
Trazodone—Leukocytosis—Fluorouracil—head and neck cancer	0.00252	0.0101	CcSEcCtD
Trazodone—Dysarthria—Fluorouracil—head and neck cancer	0.00251	0.01	CcSEcCtD
Trazodone—Photophobia—Fluorouracil—head and neck cancer	0.00223	0.00888	CcSEcCtD
Trazodone—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00199	0.00795	CcSEcCtD
Trazodone—Myocardial infarction—Vinblastine—head and neck cancer	0.00198	0.0079	CcSEcCtD
Trazodone—Photosensitivity—Fluorouracil—head and neck cancer	0.00196	0.00782	CcSEcCtD
Trazodone—Disorientation—Fluorouracil—head and neck cancer	0.00192	0.00768	CcSEcCtD
Trazodone—Hyperbilirubinaemia—Docetaxel—head and neck cancer	0.00188	0.00751	CcSEcCtD
Trazodone—Weight increased—Hydroxyurea—head and neck cancer	0.00188	0.0075	CcSEcCtD
Trazodone—Drowsiness—Hydroxyurea—head and neck cancer	0.00184	0.00735	CcSEcCtD
Trazodone—Amnesia—Fluorouracil—head and neck cancer	0.00183	0.00731	CcSEcCtD
Trazodone—Hypoaesthesia—Vinblastine—head and neck cancer	0.0018	0.0072	CcSEcCtD
Trazodone—Hearing impaired—Docetaxel—head and neck cancer	0.0018	0.00717	CcSEcCtD
Trazodone—Lethargy—Fluorouracil—head and neck cancer	0.00176	0.00701	CcSEcCtD
Trazodone—Hallucination—Hydroxyurea—head and neck cancer	0.00165	0.00657	CcSEcCtD
Trazodone—Cardiac arrest—Fluorouracil—head and neck cancer	0.00164	0.00653	CcSEcCtD
Trazodone—Ataxia—Fluorouracil—head and neck cancer	0.00162	0.00646	CcSEcCtD
Trazodone—Alopecia—Vinblastine—head and neck cancer	0.0016	0.0064	CcSEcCtD
Trazodone—Lightheadedness—Docetaxel—head and neck cancer	0.00153	0.00611	CcSEcCtD
Trazodone—Chills—Hydroxyurea—head and neck cancer	0.00148	0.00592	CcSEcCtD
Trazodone—Ill-defined disorder—Vinblastine—head and neck cancer	0.00147	0.00585	CcSEcCtD
Trazodone—Alopecia—Hydroxyurea—head and neck cancer	0.00146	0.00583	CcSEcCtD
Trazodone—Anaemia—Vinblastine—head and neck cancer	0.00146	0.00582	CcSEcCtD
Trazodone—Malaise—Vinblastine—head and neck cancer	0.00142	0.00568	CcSEcCtD
Trazodone—Vertigo—Vinblastine—head and neck cancer	0.00142	0.00566	CcSEcCtD
Trazodone—Deafness—Docetaxel—head and neck cancer	0.00139	0.00554	CcSEcCtD
Trazodone—Cardiac failure congestive—Docetaxel—head and neck cancer	0.00137	0.00547	CcSEcCtD
Trazodone—Hypertension—Vinblastine—head and neck cancer	0.00136	0.00544	CcSEcCtD
Trazodone—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00136	0.00542	CcSEcCtD
Trazodone—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00134	0.00533	CcSEcCtD
Trazodone—Anaemia—Hydroxyurea—head and neck cancer	0.00133	0.00531	CcSEcCtD
Trazodone—Discomfort—Vinblastine—head and neck cancer	0.00133	0.0053	CcSEcCtD
Trazodone—Visual disturbance—Docetaxel—head and neck cancer	0.00131	0.00523	CcSEcCtD
Trazodone—Atrial fibrillation—Docetaxel—head and neck cancer	0.00131	0.00523	CcSEcCtD
Trazodone—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00131	0.00522	CcSEcCtD
Trazodone—Myocardial infarction—Fluorouracil—head and neck cancer	0.0013	0.00519	CcSEcCtD
Trazodone—Malaise—Hydroxyurea—head and neck cancer	0.0013	0.00518	CcSEcCtD
Trazodone—Lethargy—Docetaxel—head and neck cancer	0.00127	0.00506	CcSEcCtD
Trazodone—Hyponatraemia—Docetaxel—head and neck cancer	0.00125	0.00498	CcSEcCtD
Trazodone—Anorexia—Vinblastine—head and neck cancer	0.00123	0.0049	CcSEcCtD
Trazodone—Migraine—Docetaxel—head and neck cancer	0.00122	0.00488	CcSEcCtD
Trazodone—Discomfort—Hydroxyurea—head and neck cancer	0.00121	0.00483	CcSEcCtD
Trazodone—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00118	0.00473	CcSEcCtD
Trazodone—Oedema—Hydroxyurea—head and neck cancer	0.00118	0.00469	CcSEcCtD
Trazodone—Ataxia—Docetaxel—head and neck cancer	0.00117	0.00466	CcSEcCtD
Trazodone—Paraesthesia—Vinblastine—head and neck cancer	0.00116	0.00462	CcSEcCtD
Trazodone—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00113	0.00453	CcSEcCtD
Trazodone—Anorexia—Hydroxyurea—head and neck cancer	0.00112	0.00447	CcSEcCtD
Trazodone—Decreased appetite—Vinblastine—head and neck cancer	0.00112	0.00447	CcSEcCtD
Trazodone—Constipation—Vinblastine—head and neck cancer	0.0011	0.0044	CcSEcCtD
Trazodone—Pain—Vinblastine—head and neck cancer	0.0011	0.0044	CcSEcCtD
Trazodone—Arrhythmia—Fluorouracil—head and neck cancer	0.00106	0.00424	CcSEcCtD
Trazodone—Feeling abnormal—Vinblastine—head and neck cancer	0.00106	0.00424	CcSEcCtD
Trazodone—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00105	0.0042	CcSEcCtD
Trazodone—Alopecia—Fluorouracil—head and neck cancer	0.00105	0.0042	CcSEcCtD
Trazodone—Dyspnoea—Hydroxyurea—head and neck cancer	0.00105	0.00418	CcSEcCtD
Trazodone—Somnolence—Hydroxyurea—head and neck cancer	0.00104	0.00417	CcSEcCtD
Trazodone—Decreased appetite—Hydroxyurea—head and neck cancer	0.00102	0.00408	CcSEcCtD
Trazodone—Abdominal pain—Vinblastine—head and neck cancer	0.00102	0.00407	CcSEcCtD
Trazodone—Fatigue—Hydroxyurea—head and neck cancer	0.00101	0.00404	CcSEcCtD
Trazodone—Pain—Hydroxyurea—head and neck cancer	0.00101	0.00401	CcSEcCtD
Trazodone—Constipation—Hydroxyurea—head and neck cancer	0.00101	0.00401	CcSEcCtD
Trazodone—Weight increased—Docetaxel—head and neck cancer	0.000977	0.0039	CcSEcCtD
Trazodone—Vision blurred—Fluorouracil—head and neck cancer	0.000977	0.0039	CcSEcCtD
Trazodone—Weight decreased—Docetaxel—head and neck cancer	0.000971	0.00388	CcSEcCtD
Trazodone—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000968	0.00386	CcSEcCtD
Trazodone—Anaemia—Fluorouracil—head and neck cancer	0.000958	0.00382	CcSEcCtD
Trazodone—Hypersensitivity—Vinblastine—head and neck cancer	0.000949	0.00379	CcSEcCtD
Trazodone—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000944	0.00377	CcSEcCtD
Trazodone—Myocardial infarction—Docetaxel—head and neck cancer	0.000938	0.00374	CcSEcCtD
Trazodone—Jaundice—Docetaxel—head and neck cancer	0.000933	0.00372	CcSEcCtD
Trazodone—Body temperature increased—Hydroxyurea—head and neck cancer	0.000929	0.00371	CcSEcCtD
Trazodone—Asthenia—Vinblastine—head and neck cancer	0.000925	0.00369	CcSEcCtD
Trazodone—Chest pain—Fluorouracil—head and neck cancer	0.000882	0.00352	CcSEcCtD
Trazodone—Myalgia—Fluorouracil—head and neck cancer	0.000882	0.00352	CcSEcCtD
Trazodone—Diarrhoea—Vinblastine—head and neck cancer	0.000882	0.00352	CcSEcCtD
Trazodone—Discomfort—Fluorouracil—head and neck cancer	0.000872	0.00348	CcSEcCtD
Trazodone—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000866	0.00346	CcSEcCtD
Trazodone—Hypoaesthesia—Docetaxel—head and neck cancer	0.000855	0.00341	CcSEcCtD
Trazodone—Confusional state—Fluorouracil—head and neck cancer	0.000853	0.0034	CcSEcCtD
Trazodone—Dizziness—Vinblastine—head and neck cancer	0.000852	0.0034	CcSEcCtD
Trazodone—Oedema—Fluorouracil—head and neck cancer	0.000846	0.00338	CcSEcCtD
Trazodone—Asthenia—Hydroxyurea—head and neck cancer	0.000843	0.00336	CcSEcCtD
Trazodone—Visual impairment—Docetaxel—head and neck cancer	0.000828	0.0033	CcSEcCtD
Trazodone—Tachycardia—Fluorouracil—head and neck cancer	0.000826	0.00329	CcSEcCtD
Trazodone—Vomiting—Vinblastine—head and neck cancer	0.000819	0.00327	CcSEcCtD
Trazodone—Headache—Vinblastine—head and neck cancer	0.000807	0.00322	CcSEcCtD
Trazodone—Anorexia—Fluorouracil—head and neck cancer	0.000806	0.00322	CcSEcCtD
Trazodone—Diarrhoea—Hydroxyurea—head and neck cancer	0.000804	0.00321	CcSEcCtD
Trazodone—Flushing—Docetaxel—head and neck cancer	0.000798	0.00318	CcSEcCtD
Trazodone—Hypotension—Fluorouracil—head and neck cancer	0.00079	0.00315	CcSEcCtD
Trazodone—Dizziness—Hydroxyurea—head and neck cancer	0.000777	0.0031	CcSEcCtD
Trazodone—Chills—Docetaxel—head and neck cancer	0.000771	0.00308	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000771	0.00308	CcSEcCtD
Trazodone—Arrhythmia—Docetaxel—head and neck cancer	0.000768	0.00306	CcSEcCtD
Trazodone—Nausea—Vinblastine—head and neck cancer	0.000765	0.00305	CcSEcCtD
Trazodone—Insomnia—Fluorouracil—head and neck cancer	0.000765	0.00305	CcSEcCtD
Trazodone—Paraesthesia—Fluorouracil—head and neck cancer	0.00076	0.00303	CcSEcCtD
Trazodone—Alopecia—Docetaxel—head and neck cancer	0.000759	0.00303	CcSEcCtD
Trazodone—Dyspnoea—Fluorouracil—head and neck cancer	0.000754	0.00301	CcSEcCtD
Trazodone—Somnolence—Fluorouracil—head and neck cancer	0.000752	0.003	CcSEcCtD
Trazodone—Vomiting—Hydroxyurea—head and neck cancer	0.000747	0.00298	CcSEcCtD
Trazodone—Rash—Hydroxyurea—head and neck cancer	0.000741	0.00296	CcSEcCtD
Trazodone—Dermatitis—Hydroxyurea—head and neck cancer	0.00074	0.00295	CcSEcCtD
Trazodone—Headache—Hydroxyurea—head and neck cancer	0.000736	0.00294	CcSEcCtD
Trazodone—Decreased appetite—Fluorouracil—head and neck cancer	0.000735	0.00293	CcSEcCtD
Trazodone—Dysgeusia—Docetaxel—head and neck cancer	0.000733	0.00292	CcSEcCtD
Trazodone—Back pain—Docetaxel—head and neck cancer	0.000724	0.00289	CcSEcCtD
Trazodone—Pain—Fluorouracil—head and neck cancer	0.000723	0.00289	CcSEcCtD
Trazodone—Nausea—Hydroxyurea—head and neck cancer	0.000698	0.00279	CcSEcCtD
Trazodone—Feeling abnormal—Fluorouracil—head and neck cancer	0.000697	0.00278	CcSEcCtD
Trazodone—Anaemia—Docetaxel—head and neck cancer	0.000691	0.00276	CcSEcCtD
Trazodone—Urticaria—Fluorouracil—head and neck cancer	0.000672	0.00268	CcSEcCtD
Trazodone—Syncope—Docetaxel—head and neck cancer	0.000671	0.00268	CcSEcCtD
Trazodone—Body temperature increased—Fluorouracil—head and neck cancer	0.000669	0.00267	CcSEcCtD
Trazodone—Palpitations—Docetaxel—head and neck cancer	0.000661	0.00264	CcSEcCtD
Trazodone—Loss of consciousness—Docetaxel—head and neck cancer	0.000658	0.00262	CcSEcCtD
Trazodone—Hypertension—Docetaxel—head and neck cancer	0.000646	0.00258	CcSEcCtD
Trazodone—Myalgia—Docetaxel—head and neck cancer	0.000637	0.00254	CcSEcCtD
Trazodone—Arthralgia—Docetaxel—head and neck cancer	0.000637	0.00254	CcSEcCtD
Trazodone—Chest pain—Docetaxel—head and neck cancer	0.000637	0.00254	CcSEcCtD
Trazodone—Hypersensitivity—Fluorouracil—head and neck cancer	0.000623	0.00249	CcSEcCtD
Trazodone—Dry mouth—Docetaxel—head and neck cancer	0.000623	0.00249	CcSEcCtD
Trazodone—Confusional state—Docetaxel—head and neck cancer	0.000616	0.00246	CcSEcCtD
Trazodone—Oedema—Docetaxel—head and neck cancer	0.000611	0.00244	CcSEcCtD
Trazodone—Shock—Docetaxel—head and neck cancer	0.000601	0.0024	CcSEcCtD
Trazodone—Pruritus—Fluorouracil—head and neck cancer	0.000598	0.00239	CcSEcCtD
Trazodone—Tachycardia—Docetaxel—head and neck cancer	0.000596	0.00238	CcSEcCtD
Trazodone—Anorexia—Docetaxel—head and neck cancer	0.000582	0.00232	CcSEcCtD
Trazodone—Diarrhoea—Fluorouracil—head and neck cancer	0.000579	0.00231	CcSEcCtD
Trazodone—Hypotension—Docetaxel—head and neck cancer	0.000571	0.00228	CcSEcCtD
Trazodone—Dizziness—Fluorouracil—head and neck cancer	0.000559	0.00223	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000556	0.00222	CcSEcCtD
Trazodone—Insomnia—Docetaxel—head and neck cancer	0.000552	0.0022	CcSEcCtD
Trazodone—Paraesthesia—Docetaxel—head and neck cancer	0.000548	0.00219	CcSEcCtD
Trazodone—Dyspnoea—Docetaxel—head and neck cancer	0.000544	0.00217	CcSEcCtD
Trazodone—Somnolence—Docetaxel—head and neck cancer	0.000543	0.00217	CcSEcCtD
Trazodone—Vomiting—Fluorouracil—head and neck cancer	0.000538	0.00215	CcSEcCtD
Trazodone—Rash—Fluorouracil—head and neck cancer	0.000533	0.00213	CcSEcCtD
Trazodone—Dermatitis—Fluorouracil—head and neck cancer	0.000533	0.00213	CcSEcCtD
Trazodone—Decreased appetite—Docetaxel—head and neck cancer	0.000531	0.00212	CcSEcCtD
Trazodone—Headache—Fluorouracil—head and neck cancer	0.00053	0.00211	CcSEcCtD
Trazodone—Fatigue—Docetaxel—head and neck cancer	0.000526	0.0021	CcSEcCtD
Trazodone—Pain—Docetaxel—head and neck cancer	0.000522	0.00208	CcSEcCtD
Trazodone—Constipation—Docetaxel—head and neck cancer	0.000522	0.00208	CcSEcCtD
Trazodone—Feeling abnormal—Docetaxel—head and neck cancer	0.000503	0.00201	CcSEcCtD
Trazodone—Nausea—Fluorouracil—head and neck cancer	0.000502	0.00201	CcSEcCtD
Trazodone—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000499	0.00199	CcSEcCtD
Trazodone—Abdominal pain—Docetaxel—head and neck cancer	0.000483	0.00193	CcSEcCtD
Trazodone—Body temperature increased—Docetaxel—head and neck cancer	0.000483	0.00193	CcSEcCtD
Trazodone—Hypersensitivity—Docetaxel—head and neck cancer	0.00045	0.00179	CcSEcCtD
Trazodone—Asthenia—Docetaxel—head and neck cancer	0.000438	0.00175	CcSEcCtD
Trazodone—Pruritus—Docetaxel—head and neck cancer	0.000432	0.00172	CcSEcCtD
Trazodone—Diarrhoea—Docetaxel—head and neck cancer	0.000418	0.00167	CcSEcCtD
Trazodone—Dizziness—Docetaxel—head and neck cancer	0.000404	0.00161	CcSEcCtD
Trazodone—Vomiting—Docetaxel—head and neck cancer	0.000388	0.00155	CcSEcCtD
Trazodone—Rash—Docetaxel—head and neck cancer	0.000385	0.00154	CcSEcCtD
Trazodone—Dermatitis—Docetaxel—head and neck cancer	0.000385	0.00153	CcSEcCtD
Trazodone—Headache—Docetaxel—head and neck cancer	0.000382	0.00153	CcSEcCtD
Trazodone—Nausea—Docetaxel—head and neck cancer	0.000363	0.00145	CcSEcCtD
Trazodone—HTR2A—Signaling Pathways—STAT6—head and neck cancer	1.39e-05	0.000862	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—STAT6—head and neck cancer	1.39e-05	0.00086	CbGpPWpGaD
Trazodone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	1.37e-05	0.00085	CbGpPWpGaD
Trazodone—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	1.37e-05	0.000848	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—STAT6—head and neck cancer	1.36e-05	0.000844	CbGpPWpGaD
Trazodone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	1.34e-05	0.000832	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—YAP1—head and neck cancer	1.34e-05	0.00083	CbGpPWpGaD
Trazodone—ADRA2A—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	1.32e-05	0.000817	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	1.31e-05	0.000813	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—GRP—head and neck cancer	1.3e-05	0.000807	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—DPYD—head and neck cancer	1.29e-05	0.000801	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—STAT6—head and neck cancer	1.27e-05	0.000784	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	1.24e-05	0.000769	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—YAP1—head and neck cancer	1.23e-05	0.000763	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—YAP1—head and neck cancer	1.23e-05	0.000761	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—YAP1—head and neck cancer	1.23e-05	0.00076	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—YAP1—head and neck cancer	1.21e-05	0.000747	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	1.18e-05	0.000732	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	1.18e-05	0.000732	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—YAP1—head and neck cancer	1.12e-05	0.000694	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—NAT2—head and neck cancer	1.11e-05	0.000689	CbGpPWpGaD
Trazodone—ADRA2A—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	1.08e-05	0.000668	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—NAT2—head and neck cancer	1.05e-05	0.00065	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	1.03e-05	0.000635	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—IL2—head and neck cancer	1.03e-05	0.000635	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—TYMS—head and neck cancer	1.02e-05	0.000632	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—IL2—head and neck cancer	1.02e-05	0.000629	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—GSTM1—head and neck cancer	1.01e-05	0.000624	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	9.93e-06	0.000614	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—DPYD—head and neck cancer	9.77e-06	0.000605	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—GPX1—head and neck cancer	9.66e-06	0.000598	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—CYP1A1—head and neck cancer	9.56e-06	0.000592	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—YAP1—head and neck cancer	9.27e-06	0.000574	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—IL2—head and neck cancer	9.23e-06	0.000571	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—DPYD—head and neck cancer	9.21e-06	0.00057	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—YAP1—head and neck cancer	8.74e-06	0.000541	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—VEGFA—head and neck cancer	8.72e-06	0.000539	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	8.38e-06	0.000519	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—IL2—head and neck cancer	8.25e-06	0.00051	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—MAPK3—head and neck cancer	8.25e-06	0.00051	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—IL2—head and neck cancer	8.2e-06	0.000508	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—TYMS—head and neck cancer	8.05e-06	0.000498	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—GSTM1—head and neck cancer	7.96e-06	0.000492	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—NOTCH1—head and neck cancer	7.93e-06	0.000491	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—MAPK1—head and neck cancer	7.85e-06	0.000485	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—GPX1—head and neck cancer	7.62e-06	0.000472	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—CYP1A1—head and neck cancer	7.54e-06	0.000467	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—IL2—head and neck cancer	7.49e-06	0.000463	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—IL2—head and neck cancer	7.45e-06	0.000461	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—MAPK3—head and neck cancer	7.42e-06	0.000459	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—TYMS—head and neck cancer	7.38e-06	0.000457	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—GSTM1—head and neck cancer	7.29e-06	0.000451	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—IL2—head and neck cancer	7.12e-06	0.000441	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—IL2—head and neck cancer	7.11e-06	0.00044	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—MAPK1—head and neck cancer	7.06e-06	0.000437	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—EGFR—head and neck cancer	7.06e-06	0.000437	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—GPX1—head and neck cancer	6.98e-06	0.000432	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—IL2—head and neck cancer	6.98e-06	0.000432	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—CYP1A1—head and neck cancer	6.91e-06	0.000428	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—NAT2—head and neck cancer	6.86e-06	0.000425	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—PIK3CA—head and neck cancer	6.81e-06	0.000421	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—PIK3CA—head and neck cancer	6.75e-06	0.000418	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—TP53—head and neck cancer	6.59e-06	0.000408	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—IL2—head and neck cancer	6.48e-06	0.000401	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—IL2—head and neck cancer	6.47e-06	0.0004	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—IL2—head and neck cancer	6.46e-06	0.000399	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—NOTCH1—head and neck cancer	6.43e-06	0.000398	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—NOTCH1—head and neck cancer	6.4e-06	0.000396	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—IL2—head and neck cancer	6.33e-06	0.000392	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—HRAS—head and neck cancer	6.3e-06	0.00039	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—PIK3CA—head and neck cancer	6.13e-06	0.000379	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—MAPK3—head and neck cancer	6.02e-06	0.000373	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—DPYD—head and neck cancer	6.02e-06	0.000372	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—MAPK3—head and neck cancer	5.99e-06	0.000371	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—IL2—head and neck cancer	5.89e-06	0.000364	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—MAPK1—head and neck cancer	5.73e-06	0.000354	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—EGFR—head and neck cancer	5.73e-06	0.000354	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—YAP1—head and neck cancer	5.71e-06	0.000353	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—MAPK1—head and neck cancer	5.7e-06	0.000353	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—EGFR—head and neck cancer	5.7e-06	0.000353	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—PTGS2—head and neck cancer	5.69e-06	0.000352	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—HRAS—head and neck cancer	5.67e-06	0.000351	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—TYMS—head and neck cancer	5.57e-06	0.000344	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—AKT1—head and neck cancer	5.56e-06	0.000344	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—NOTCH1—head and neck cancer	5.55e-06	0.000344	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—NOTCH1—head and neck cancer	5.54e-06	0.000343	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—AKT1—head and neck cancer	5.51e-06	0.000341	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—GSTM1—head and neck cancer	5.5e-06	0.000341	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—PIK3CA—head and neck cancer	5.47e-06	0.000339	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IL2—head and neck cancer	5.46e-06	0.000338	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—PIK3CA—head and neck cancer	5.45e-06	0.000337	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—NOTCH1—head and neck cancer	5.44e-06	0.000337	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CCND1—head and neck cancer	5.32e-06	0.000329	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—GPX1—head and neck cancer	5.27e-06	0.000326	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—TYMS—head and neck cancer	5.25e-06	0.000325	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—CYP1A1—head and neck cancer	5.22e-06	0.000323	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—MAPK3—head and neck cancer	5.2e-06	0.000322	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—MAPK3—head and neck cancer	5.19e-06	0.000321	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—GSTM1—head and neck cancer	5.19e-06	0.000321	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—PTEN—head and neck cancer	5.13e-06	0.000318	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—MAPK3—head and neck cancer	5.09e-06	0.000315	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—NOTCH1—head and neck cancer	5.05e-06	0.000313	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—AKT1—head and neck cancer	5.01e-06	0.00031	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—PIK3CA—head and neck cancer	4.97e-06	0.000308	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—GPX1—head and neck cancer	4.97e-06	0.000307	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—PTEN—head and neck cancer	4.96e-06	0.000307	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—MAPK1—head and neck cancer	4.95e-06	0.000306	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—EGFR—head and neck cancer	4.95e-06	0.000306	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—PIK3CA—head and neck cancer	4.95e-06	0.000306	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—MAPK1—head and neck cancer	4.94e-06	0.000306	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—EGFR—head and neck cancer	4.94e-06	0.000306	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CYP1A1—head and neck cancer	4.92e-06	0.000304	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—MAPK1—head and neck cancer	4.85e-06	0.0003	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—EGFR—head and neck cancer	4.84e-06	0.0003	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—MAPK3—head and neck cancer	4.73e-06	0.000293	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—PIK3CA—head and neck cancer	4.73e-06	0.000293	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—PIK3CA—head and neck cancer	4.72e-06	0.000292	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—VEGFA—head and neck cancer	4.64e-06	0.000287	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—PIK3CA—head and neck cancer	4.63e-06	0.000287	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—HRAS—head and neck cancer	4.6e-06	0.000285	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—STAT3—head and neck cancer	4.59e-06	0.000284	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—HRAS—head and neck cancer	4.58e-06	0.000283	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—MAPK1—head and neck cancer	4.5e-06	0.000279	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—EGFR—head and neck cancer	4.5e-06	0.000279	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PTGS2—head and neck cancer	4.49e-06	0.000278	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—AKT1—head and neck cancer	4.47e-06	0.000277	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—AKT1—head and neck cancer	4.45e-06	0.000275	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IL2—head and neck cancer	4.42e-06	0.000274	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IL2—head and neck cancer	4.4e-06	0.000272	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—MAPK3—head and neck cancer	4.39e-06	0.000271	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CCND1—head and neck cancer	4.31e-06	0.000267	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—PIK3CA—head and neck cancer	4.3e-06	0.000266	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—PIK3CA—head and neck cancer	4.29e-06	0.000266	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CCND1—head and neck cancer	4.29e-06	0.000265	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—PIK3CA—head and neck cancer	4.29e-06	0.000265	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—PIK3CA—head and neck cancer	4.2e-06	0.00026	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—MAPK1—head and neck cancer	4.17e-06	0.000258	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—EGFR—head and neck cancer	4.17e-06	0.000258	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—PTEN—head and neck cancer	4.16e-06	0.000258	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—PTEN—head and neck cancer	4.14e-06	0.000256	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PTGS2—head and neck cancer	4.11e-06	0.000254	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—AKT1—head and neck cancer	4.06e-06	0.000251	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—AKT1—head and neck cancer	4.04e-06	0.00025	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—HRAS—head and neck cancer	3.97e-06	0.000246	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—HRAS—head and neck cancer	3.96e-06	0.000245	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PTEN—head and neck cancer	3.91e-06	0.000242	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—PIK3CA—head and neck cancer	3.91e-06	0.000242	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—HRAS—head and neck cancer	3.89e-06	0.000241	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—AKT1—head and neck cancer	3.86e-06	0.000239	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—AKT1—head and neck cancer	3.85e-06	0.000239	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IL2—head and neck cancer	3.82e-06	0.000236	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IL2—head and neck cancer	3.81e-06	0.000236	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—AKT1—head and neck cancer	3.78e-06	0.000234	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—VEGFA—head and neck cancer	3.76e-06	0.000233	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IL2—head and neck cancer	3.74e-06	0.000232	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—VEGFA—head and neck cancer	3.74e-06	0.000231	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CCND1—head and neck cancer	3.73e-06	0.000231	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—STAT3—head and neck cancer	3.72e-06	0.00023	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CCND1—head and neck cancer	3.72e-06	0.00023	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—STAT3—head and neck cancer	3.7e-06	0.000229	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CCND1—head and neck cancer	3.65e-06	0.000226	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—PIK3CA—head and neck cancer	3.62e-06	0.000224	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—HRAS—head and neck cancer	3.61e-06	0.000224	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PTEN—head and neck cancer	3.6e-06	0.000223	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PTEN—head and neck cancer	3.59e-06	0.000222	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PTEN—head and neck cancer	3.59e-06	0.000222	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MAPK3—head and neck cancer	3.56e-06	0.00022	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MAPK3—head and neck cancer	3.54e-06	0.000219	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PTEN—head and neck cancer	3.52e-06	0.000218	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—AKT1—head and neck cancer	3.51e-06	0.000217	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—AKT1—head and neck cancer	3.51e-06	0.000217	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TP53—head and neck cancer	3.5e-06	0.000217	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—AKT1—head and neck cancer	3.5e-06	0.000217	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—PIK3CA—head and neck cancer	3.5e-06	0.000217	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IL2—head and neck cancer	3.48e-06	0.000215	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—AKT1—head and neck cancer	3.44e-06	0.000213	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—TYMS—head and neck cancer	3.43e-06	0.000212	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GSTM1—head and neck cancer	3.39e-06	0.00021	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CCND1—head and neck cancer	3.39e-06	0.00021	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MAPK1—head and neck cancer	3.38e-06	0.000209	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—EGFR—head and neck cancer	3.38e-06	0.000209	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MAPK1—head and neck cancer	3.37e-06	0.000208	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—EGFR—head and neck cancer	3.37e-06	0.000208	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—HRAS—head and neck cancer	3.35e-06	0.000207	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PTEN—head and neck cancer	3.27e-06	0.000202	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—VEGFA—head and neck cancer	3.25e-06	0.000201	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GPX1—head and neck cancer	3.25e-06	0.000201	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—VEGFA—head and neck cancer	3.24e-06	0.000201	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—STAT3—head and neck cancer	3.22e-06	0.000199	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CYP1A1—head and neck cancer	3.21e-06	0.000199	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—STAT3—head and neck cancer	3.21e-06	0.000199	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—AKT1—head and neck cancer	3.19e-06	0.000198	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—VEGFA—head and neck cancer	3.18e-06	0.000197	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—STAT3—head and neck cancer	3.15e-06	0.000195	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PTGS2—head and neck cancer	3.1e-06	0.000192	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MAPK3—head and neck cancer	3.07e-06	0.00019	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MAPK3—head and neck cancer	3.07e-06	0.00019	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MAPK3—head and neck cancer	3.01e-06	0.000186	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—AKT1—head and neck cancer	2.96e-06	0.000183	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—VEGFA—head and neck cancer	2.95e-06	0.000183	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—PIK3CA—head and neck cancer	2.94e-06	0.000182	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—STAT3—head and neck cancer	2.93e-06	0.000181	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MAPK1—head and neck cancer	2.92e-06	0.000181	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PTGS2—head and neck cancer	2.92e-06	0.000181	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—EGFR—head and neck cancer	2.92e-06	0.000181	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—PIK3CA—head and neck cancer	2.92e-06	0.000181	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MAPK1—head and neck cancer	2.92e-06	0.000181	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—EGFR—head and neck cancer	2.92e-06	0.00018	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MAPK1—head and neck cancer	2.86e-06	0.000177	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—EGFR—head and neck cancer	2.86e-06	0.000177	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—AKT1—head and neck cancer	2.86e-06	0.000177	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TP53—head and neck cancer	2.84e-06	0.000176	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TP53—head and neck cancer	2.83e-06	0.000175	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MAPK3—head and neck cancer	2.8e-06	0.000173	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PIK3CA—head and neck cancer	2.76e-06	0.000171	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—HRAS—head and neck cancer	2.72e-06	0.000168	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PTEN—head and neck cancer	2.71e-06	0.000167	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—HRAS—head and neck cancer	2.7e-06	0.000167	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MAPK1—head and neck cancer	2.66e-06	0.000165	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—EGFR—head and neck cancer	2.66e-06	0.000165	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PTEN—head and neck cancer	2.55e-06	0.000158	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PIK3CA—head and neck cancer	2.54e-06	0.000157	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PIK3CA—head and neck cancer	2.53e-06	0.000157	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PIK3CA—head and neck cancer	2.53e-06	0.000157	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PIK3CA—head and neck cancer	2.48e-06	0.000154	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TP53—head and neck cancer	2.45e-06	0.000152	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TP53—head and neck cancer	2.45e-06	0.000152	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TP53—head and neck cancer	2.4e-06	0.000149	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—AKT1—head and neck cancer	2.4e-06	0.000148	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—AKT1—head and neck cancer	2.39e-06	0.000148	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—HRAS—head and neck cancer	2.35e-06	0.000145	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—HRAS—head and neck cancer	2.34e-06	0.000145	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PIK3CA—head and neck cancer	2.31e-06	0.000143	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—HRAS—head and neck cancer	2.3e-06	0.000142	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—AKT1—head and neck cancer	2.25e-06	0.00014	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TP53—head and neck cancer	2.23e-06	0.000138	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—HRAS—head and neck cancer	2.14e-06	0.000132	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—AKT1—head and neck cancer	2.07e-06	0.000128	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—AKT1—head and neck cancer	2.07e-06	0.000128	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—AKT1—head and neck cancer	2.07e-06	0.000128	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—AKT1—head and neck cancer	2.03e-06	0.000126	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.91e-06	0.000118	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PIK3CA—head and neck cancer	1.91e-06	0.000118	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—AKT1—head and neck cancer	1.89e-06	0.000117	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PIK3CA—head and neck cancer	1.8e-06	0.000111	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PTEN—head and neck cancer	1.67e-06	0.000103	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—AKT1—head and neck cancer	1.56e-06	9.65e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—AKT1—head and neck cancer	1.47e-06	9.09e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.18e-06	7.28e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—AKT1—head and neck cancer	9.61e-07	5.94e-05	CbGpPWpGaD
